Is Fce 24304 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Fce 24304? Is Fce 24304 safe for nursing mother and child? Does Fce 24304 extracts into breast milk? Does Fce 24304 has any long term or short term side effects on infants? Can Fce 24304 influence milk supply or can Fce 24304 decrease milk supply in lactating mothers?
Fce 24304 lactation summary
- DrLact safety Score for Fce 24304 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of Fce 24304 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that Fce 24304 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using Fce 24304 .
- Usage of Fce 24304 is in contradiction to breastfeeding hence if it is must to use Fce 24304 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Fce 24304 usage in lactation
Steroidal aromatase inhibitor. Using this drug while breastfeeding in not recommended
Answer by DrLact: About Fce 24304 usage in lactation
No information is available on the use of Fce 24304 during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. The manufacturer recommends that breastfeeding be discontinued during Fce 24304 therapy and for 1 month after the last dose.
Alternate Drugs
Vincristine(Dangerous)
Dactinomycin(Dangerous)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Ipilimumab(Unsafe)
Mercaptopurine(Safe)
Cetuximab(Unsafe)
Carboplatin(Dangerous)
Gemcitabine(Dangerous)
Paclitaxel(Dangerous)
Hydroxyurea(Low Risk)
Fluorouracil(Dangerous)
Etoposide(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Doxorubicin(Dangerous)
Rituximab(Low Risk)
Vinblastine(Dangerous)
Cyclophosphamide(Dangerous)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Busulfan(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Letrozole(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Cladribine(Dangerous)
Exemestane(Dangerous)
Letrozole(Dangerous)